New Calcipotriol EP Impurities A, C, D, F, and I

February 10, 2015
Acanthus Research Inc. has expanded its offering of Calcipotriol EP Impurities (A, C, D, F and I). Click here to view the structures. Each impurity standard is accompanied with a Certificate of...
Read More

Clindamycin-Related Analytical Reference Standards

February 2, 2015
Acanthus Research Inc. now offers a large collection of clindamycin-related analytical reference standards. All standards are of high purity and are accompanied by Certificate of Analysis. To request the CofA...
Read More

Nilotinib Potentially Genotoxic Impurities

February 2, 2015
Analytical reference standards of three potentially genotoxic impurities of nilotinib (Tasigna) are now available from Acanthus Research: Nilotinib Genotoxic Impurity 1 (CAS No. 641571-11-1), Nilotinib Genotoxic Impurity 2 (CAS No.1157857-29-8), and...
Read More

Lapatinib Potentially Genotoxic Impurities

February 1, 2015
Analytical reference standards of two potentially genotoxic impurities of lapatinib (Tykerb, Tyverb) are now available from Acanthus Research Inc.: Lapatinib Genotoxic Impurity 1 (CAS No. 202197-26-0) and Lapatinib Genotoxic Impurity 2 (CAS...
Read More

Control of Potentially Genotoxic Impurities in Drug Products

January 1, 2015
Genotoxin is a substance capable of damaging DNA causing mutations (mutagen), cancer (carcinogen), or birth defect (teratogen). The European and North American regulatory agencies recognized in mid 2000’s the importance...
Read More

Montelukast Impurity Standards

May 10, 2014
Acanthus Research Inc. now offers all USP impurity reference standards for montelukast sodium, as listed in the USP monograph as well as montelukast lactone potential process impurity reference standard. The...
Read More